» Articles » PMID: 38140666

Involvement of a Rarely Used Splicing SD2b Site in the Regulation of HIV-1 MRNA Production As Revealed by a Growth-Adaptive Mutation

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Dec 23
PMID 38140666
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously reported an HIV-1 mutant designated NL-Y226tac that expresses Vif at an ultra-low level, being replication-defective in high-APOBEC3G cells, such as H9. It carries a synonymous mutation within the splicing SA1 site relative to its parental clone. In order to determine whether a certain mutant(s) emerges during multi-infection cycles, we maintained H9 cells infected with a relatively low or high input of NL-Y226tac for extended time periods. Unexpectedly, we reproducibly identified a g5061a mutation in the SD2b site in the two independent long-term culture experiments that partially increases Vif expression and replication ability. Importantly, the adaptive mutation g5061a was demonstrated to enhance mRNA production by activation of the SA1 site mediated through increasing usage of a rarely used SD2b site. In the long-term culture initiated by a high virus input, we additionally found a Y226Fttc mutation at the original Y226tac site in SA1 that fully restores Vif expression and replication ability. As expected, the adaptive mutation Y226Fttc enhances mRNA production through increasing the splicing site usage of SA1. Our results here revealed the importance of the SD2b nucleotide sequence in producing mRNA involved in the HIV-1 adaptation and of mutual antagonism between Vif and APOBEC3 proteins in HIV-1 adaptation/evolution and survival.

Citing Articles

Interferon-Regulated Expression of Cellular Splicing Factors Modulates Multiple Levels of HIV-1 Gene Expression and Replication.

Roesmann F, Muller L, Klaassen K, Hess S, Widera M Viruses. 2024; 16(6).

PMID: 38932230 PMC: 11209495. DOI: 10.3390/v16060938.

References
1.
Jordan-Paiz A, Franco S, Martinez M . Impact of Synonymous Genome Recoding on the HIV Life Cycle. Front Microbiol. 2021; 12:606087. PMC: 8007914. DOI: 10.3389/fmicb.2021.606087. View

2.
Harris R, Hultquist J, Evans D . The restriction factors of human immunodeficiency virus. J Biol Chem. 2012; 287(49):40875-83. PMC: 3510791. DOI: 10.1074/jbc.R112.416925. View

3.
Stupfler B, Verriez C, Gallois-Montbrun S, Marquet R, Paillart J . Degradation-Independent Inhibition of APOBEC3G by the HIV-1 Vif Protein. Viruses. 2021; 13(4). PMC: 8066197. DOI: 10.3390/v13040617. View

4.
Desimmie B, Delviks-Frankenberrry K, Burdick R, Qi D, Izumi T, Pathak V . Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all. J Mol Biol. 2013; 426(6):1220-45. PMC: 3943811. DOI: 10.1016/j.jmb.2013.10.033. View

5.
PLATT E, Wehrly K, Kuhmann S, Chesebro B, Kabat D . Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol. 1998; 72(4):2855-64. PMC: 109730. DOI: 10.1128/JVI.72.4.2855-2864.1998. View